PharmaJet was founded to address specific market needs.
Worldwide, over 17 billion needle/syringes are used annually, including 2 billion of these for vaccine delivery. In the developed world, children receive 5-13 vaccinations from birth through adolescence, contributing to a $20B vaccine market growing at 15%.
PharmaJet injectors deliver a fixed 0.5 mL liquid volume to the intramuscular (IM) and subcutaneous (SC) tissue depths.
0.5 mL is the standard volume for most childhood vaccines, travelers’ vaccines, seasonal flu vaccines, pandemic flu, young adult vaccines and some therapeutics.
PharmaJet is also developing an injector which will deliver a fixed 0.1mL liquid volume to the intradermal (ID) tissue depth.Applications
.IM, SC, Intradermal
.Benefits of PharmaJet
.Benefits of Needle-free